Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy
- 28 February 1991
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 12 (2) , 113-121
- https://doi.org/10.1016/0169-6009(91)90040-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- RENAL PHOSPHATE THRESHOLD AND RESPONSE TO PAMIDRONATE IN HUMORAL HYPERCALCAEMIA OF MALIGNANCYThe Lancet, 1989
- Diphosphonates and phosphate homoeostasis in manClinical Science, 1988
- Effect of single high dose infusions of aminohydroxypropylidene diphosphonate on hypercalcaemia caused by cancer.BMJ, 1987
- Therapy of hypercalcemia of malignancyThe American Journal of Medicine, 1987
- Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonateCalcified Tissue International, 1986
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calciumCalcified Tissue International, 1982
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Diphosphonate Therapy of Paget's Disease of BoneJournal of Clinical Endocrinology & Metabolism, 1977
- DIPHOSPHONATES IN PAGET'S DISEASEThe Lancet, 1974